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Research
Bisphenol A (BPA), a chemical compound 
found in plastic products, is increasingly being 
identified as a pervasive industrial pollutant. 
In fact, accumulating evidence indicates that 
the human population is widely exposed to 
BPA through polycarbonate plastics, res-
ins, and sealants (Brotons et al. 1995; Olea 
et al. 1996); thus, environmental BPA is an   
endocrine-disrupting chemical that can poten-
tially affect human health (Kang et al. 2006; 
vom Saal and Hughes 2005; vom Saal et al. 
2005). Importantly, previous studies have 
detected BPA in serum of pregnant women 
and in cord serum collected at birth (Ikezuki 
et al. 2002; Takahashi and Oishi 2000) and 
reported that BPA accumulates early in fetuses 
(Schonfelder et al. 2002b). Moreover, BPA 
content was higher in amniotic fluid and pla-
centa than in maternal serum (Ikezuki et al. 
2002; Takahashi and Oishi 2000). In utero 
exposure to BPA has been shown to cause 
adverse effects in offspring, for example:
• Accelerated puberty and increased body 
weight in female mice when gestating dams 
were injected with BPA (2 and 20 µg/kg) 
(Honma et al. 2002)
• Alterations in rodent mammary gland when 
dams were implanted with osmotic pumps 
delivering 25–250 µg/kg/day (Markey et al. 
2001)
• Abnormal female genital tract development 
when dams were exposed to BPA through 
gavage (Schonfelder et al. 2002a) or osmotic 
pumps (Markey et al. 2005)
• In males, altered structure and function of 
the ventral prostate when dams were exposed 
to BPA through osmotic pump delivering 
BPA between 25 and 250 µg/kg/day (Ramos 
et al. 2001). 
Mechanistically, BPA is a well-known estro-
genic compound that binds to estrogen   
receptor α (ERα) and ERβ (Hiroi et al. 1999; 
Kurosawa et al. 2002). BPA can also act as an 
antagonist of the thyroid hormone receptor 
(Moriyama et al. 2002; Zoeller et al. 2005) 
and targets protein disulfide isomerase, a 
multi  functional protein critically involved in 
the folding, assembly, and shedding of many 
cellu  lar proteins (Hiroi et al. 2006; Okada 
et al. 2005).
The first evidence that perinatal BPA 
exposure could lead to altered metabolic fea-
tures was provided by Rubin et al. (2001), 
who found that perinatal exposure to BPA in 
Sprague-Dawley rats resulted in an increase 
in body weight apparent soon after birth 
and continuing into adulthood. In addition, 
numerous in vitro studies have shown meta-
bolic actions of BPA on adipo  cyte cell lines. 
First, BPA interferes with glucose homeo-
stasis. BPA treatment enhanced basal and 
insulin-stimulated glucose uptake in 3T3-
F442A adipo  cytes because of an increased 
amount of glucose transporter 4 (GLUT4) 
protein (Sakurai et al. 2004). Second, BPA 
triggers adipocyte differentiation: The con-
fluent cultures of 3T3-L1 fibroblasts treated 
with BPA presented an increase in tri-
glyceride content, lipoprotein lipase activ-
ity, and glycerol phosphate dehydrogenase 
activity, suggesting that BPA by itself can 
promote 3T3-L1 fibroblasts to differenti-
ate into adipocytes (Masuno et al. 2002). 
3T3-L1 cells treated with BPA also show 
increased levels of lipoprotein lipase and 
adipocyte-specific fatty acid binding protein 
(aP2) mRNAs, confirming that BPA is able 
to accelerate the terminal differentiation of 
3T3-L1 cells into adipocytes (Masuno et al. 
2005). To determine whether peri  natal expo-
sure to BPA could have an impact on adi-
pogenesis in vivo, thus contributing to the 
partially unexplained increased prevalence 
of the metabolic syndrome in industrialized 
countries, we studied adipose tissue deposi-
tion and its profile of gene expression at 
weaning [postnatal day (PND) 21]. We also 
monitored food intake and body weight dur-
ing growth in peri  natally BPA-exposed ani-
mals fed with a standard chow or a high-fat 
diet after weaning.
Address correspondence to E. Somm, Department 
of Pediatrics, Geneva University Hospitals, 1211 
Geneva 4, Switzerland. Telephone: 41-22-382-
45-69. Fax: 41-22-347-59-79. E-mail: emmanuel.
somm@medecine.unige.ch
This work was supported by the Swiss National 
Research  Program  50  Endocrine  Disruptors: 
Relevance to Humans, Animals and Ecosystems 
grants to M.L.A. and P.S.H.
The authors declare they have no competing 
  financial interests.
Received 7 February 2008; accepted 29 June 2009.
Perinatal Exposure to Bisphenol A Alters Early Adipogenesis in the Rat
Emmanuel Somm,1,2 Valérie M. Schwitzgebel,2 Audrey Toulotte,1,2 Christopher R. Cederroth,3 
Christophe Combescure,4 Serge Nef,3 Michel L. Aubert,1,2 and Petra S. Hüppi2
1Faculty of Medicine, University of Geneva, Geneva, Switzerland; 2Department of Pediatrics, Geneva University Hospitals, Geneva, 
Switzerland; 3Department of Genetic Medicine and Development and National Center for Competence in Research—Frontiers in Genetics, 
Faculty of Medicine, University of Geneva, Geneva, Switzerland; 4Department of Clinical Epidemiology, Geneva University Hospitals, 
Geneva, Switzerland
Ba c k g r o u n d: The causes of the current obesity pandemic have not been fully elucidated. 
Implication of environmental endocrine disruptors such as bisphenol A (BPA) on adipose tissue 
development has been poorly investigated.
oBjectives: The aim of the present study was to evaluate the effects of perinatal exposure to BPA 
on early adipose storage at weaning.
Me t h o d s : Pregnant Sprague-Dawley rats had access to drinking water containing 1 mg/L BPA from 
day 6 of gestation through the end of lactation. Pups were weaned on postnatal day (PND) 21. At 
that time, we investigated peri  gonadal adipose tissue of pups (weight, histology, gene expression). 
For the remaining animals, we recorded body weight and food intake for animals on either standard 
chow or a high-fat diet. 
re s u l t s: Gestational exposure to BPA did not alter the sex ratio or litter size at birth. On PND1, 
the weight of male and female BPA-exposed pups was increased. On PND21, body weight was 
increased only in females, in which parametrial white adipose tissue (pWAT) weight was increased 
about 3-fold. This excess of pWAT was associated with adipocyte hypertrophy and over  expression 
of lipogenic genes such as C/EBP-α (CAAT enhancer binding protein alpha), PPAR-γ (peroxisome 
proliferator-activated receptor gamma), SREBP-1C (sterol regulatory element binding protein-1C), 
LPL (lipoprotein lipase), FAS (fatty acid synthase), and SCD-1 (stearoyl-CoA desaturase 1). In addi-
tion, gene expression of SREBP-1C, FAS, and ACC (acetyl-CoA carboxylase) was also increased in 
liver from BPA-exposed females at PND21, without a change in circulating lipids and glucose. After 
weaning, perinatal BPA exposure predisposed to overweight in a sex- and diet-dependent manner. 
We observed no change in food intake due to perinatal BPA exposure in rats on either standard 
chow or a high-fat diet.
co n c l u s i o n s: Perinatal exposure to a low dose of BPA increased adipogenesis in females at wean-
ing. Adult body weight may be programmed during early life, leading to changes dependent on the 
sex and the nutritional status. Although further studies are required to understand the mechanisms 
of BPA action in early life, these results are particularly important with regard to the increasing 
prevalence of childhood obesity and the context-dependent action of endocrine disruptors.
key w o r d s : adipocyte, adipose tissue, bisphenol A, food intake, obesity. Environ Health Perspect 
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Materials and Methods
Animal care, diets, and BPA exposure before 
weaning. All animals used in this study were 
treated humanely and with regard for alle-
viation of suffering. All experimental proto-
cols were approved by the State of Geneva 
Veterinary Office (Geneva, Switzerland). 
Virgin female and male genitor Sprague-
Dawley rats were purchased from Taconic 
Europe (Laven, Denmark) and provided with 
a rodent experimental diet (KLIBA NAFAG 
3250; Provimi Kliba, Kaiseraugst, Switzerland) 
low in phytoestrogens, with genistein content 
below the detection limit, as stated by the pro-
vider. Animals were given this diet 10 days 
before mating until the end of gestation. We 
considered the day sperm-positive smears were 
obtained to be gestation day (GD) 0. Pregnant 
rats were housed individually under standard 
conditions (22°C, 12-hr light–dark cycle), with 
free access to food and water. To mimic the 
most likely route of human exposure, pregnant 
females were exposed to BPA at concentrations 
of 1 mg/L in water beginning on GD6 until 
the end of lactation (PND21 of offspring), 
as previously described (Rubin et al. 2001). 
Control females were given water containing 
1% ethanol, the concentration used as a vehicle 
for the BPA solution. Based on the measure-
ments of the volume reduction in the water 
bottle, not accounting for possible leakage, 
evaporation, or spillage, we estimated the mean 
levels of BPA consumed daily by pregnant 
females at the end of gestation to be approxi-
mately 70 µg BPA/kg/day. Assuming that all 
water lost from the bottle was consumed, the 
estimates of the level of BPA exposure may be 
somewhat higher than actual exposure levels. 
Water bottles and cages made of polypropyl-
ene used for all of these studies were devoid of 
BPA and analog compounds to avoid potential 
contamination from sources other than admin-
istered drinking water. Tap water locally dis-
tributed in our animal facilities is not tested for 
BPA content, but independent organizations 
controlling the quality of water in Lake Geneva 
(from which water originates before physico-
chemical treatment) evaluated its concentration 
as approximately 7 ng/L (Edder et al. 2006). 
We consider the residual BPA content in tap 
water, after the complex process of filtration, to 
be too low to interfere with the dose studied. 
Before PND21, maternal food intake, volume 
of water consumed, and body weight gain were 
measured daily. Body weight of offspring was 
measured on PND1 (at the same time as deter-
mination of sex ratio and number of pups per 
litter) and on PND21.
Animal care and diets after weaning. On 
PND21, 2 hr after maternal separation, one 
cohort of both perinatally BPA-exposed and 
control animals (n = 10 animals per sex in each 
group, belonging to three different litters of 
each group) was anesthetized with isoflurane. 
After animals were weighed and anogenital 
distance was meas  ured, animals were sacrificed 
by decapitation. Truncal blood was collected 
and centrifuged, and plasma was immediately 
frozen for later analysis. Epididymal white adi-
pose tissue (eWAT) was removed from areas 
surrounding the epididymis and testis, whereas 
parametrial white adipose tissue (pWAT) was 
collected from homologous areas surrounding 
the uterus. Brown adipose tissue (BAT) was 
collected from the inter  scapular region and 
separated from the attached white adipose tis-
sue. These fat depots, in addition to the liver, 
were weighed before being frozen in liquid 
nitrogen and stored at −80°C for later molecu-
lar analysis. Adipose depots were selected and 
dissected using previously described protocols 
(Ailhaud 2001). 
A second cohort of peri  natally BPA-
exposed and control animals was studied 
during the post  weaning period. On PDN21, 
these animals were given normal drinking 
water and were fed ad libitum with a standard 
chow diet (7% of the calories from fat, 76% 
from carbo  hydrates, and 17% from proteins) 
or with a high-fat diet (40% of the calories 
from fat, 43% from carbohydrates, and 17% 
from proteins). Metabolizable energy of the 
standard chow and high-fat diets was 2.6 and 
4.3 kcal/g, respectively, as described by the 
manufacturer (Provimi Kliba). We measured 
body weight weekly from weeks 4 to 14. Food 
intake was estimated by the weight of solid 
pellets placed on grids on top of the poly-
propylene cages, which was measured weekly 
from weeks 8 to 14. We estimated the values 
to be accurate because we were unable to visu-
ally detect pieces of pellet or powder in the 
bottoms of the cages.
Histologic examination of adipose tissue. 
pWAT of 21-day-old BPA-exposed and control 
rats was fixed in a paraformaldehyde solution 
for 24 hr and embedded in paraffin. Sections 
(5 µm) were cut using a microtome (Leica 
Microsystems, Wetzlar, Germany) and then 
stained with hematoxylin/eosin. Photographs 
were taken using an Axiocam camera (Carl 
Zeiss, Gottingen, Germany).
RNA preparation and mRNA quantifica-
tion. Adipose tissue depots and liver were 
carefully dissected and weighed before being 
frozen in liquid nitrogen and stored at −80°C. 
Total RNA was subsequently extracted using 
Trizol reagent (Invitrogen, Basel, Switzerland), 
according to the manufacturer’s instructions. 
We assessed RNA quality using the Agilent 
RNA 6000 Nanokit with an Agilent 2100 
Bioanalyzer (Agilent Technologies, Basel, 
Switzerland). Samples with inadequate coef-
ficients of purity were excluded from the 
subsequent analyses (reverse transcription 
and real-time PCR). We reverse-transcribed 
5 µg total RNA using 800 units Moloney 
murine leukemia virus reverse transcriptase 
(Invitrogen) in the presence of 0.3 units/µL 
RNAsin ribo  nuclease inhibitor (Promega 
Corp, Madison, WI, USA), 7.5 µM random 
primers [oligo(dN)6], 1.2 mM dNTP (deoxy-
ribo  nucleotide tri  phosphate), and 12 µM 
DTT (dithio  threitol). The relative expression 
of transcripts coding for rat C/EBP-α (CAAT 
enhancer binding protein alpha), PPAR‑γ 
(peroxisome proliferator-activated receptor 
gamma), SREBP‑1C (sterol regu  la  tory element 
binding protein-1C), GATA‑2 (GATA binding 
protein 2), Pref‑1 (pre  adipo  cyte factor 1), LPL 
(lipo  protein lipase), ACC (acetyl-CoA carboxy-
lase), FAS (fatty acid synthase), PPAR‑α (per-
oxisome proliferator activated receptor-alpha), 
PGC‑1α (peroxisome proliferator-activated 
receptor-γ coactivator 1α), SCD‑1 (stearoyl-
CoA desaturase 1), and GLUT4 were deter-
mined by quantitative real-time PCR using 
an ABI 7000 Sequence Detection System 
(Applied Biosystems, Applera Europe, 
Rotkreuz, Switzerland) and were normalized 
using the ribosomal housekeeping gene 36B4. 
We quantified PCR products using the SYBR 
Green Core Reagent kit (Applied Biosystems). 
Primers were designed using Primer Express 
software (Applied Biosystems) and tested for 
efficiency prior to use. The sequences of the 
primers used are listed below:
C/EBP-α: 
F: AGTTGACCAGTGACAATGACCG; 
R: TCAGGCAGCTGGCGGAAGAT
PPAR-γ: 
F: CTGACCCAATGGTTGCTGATTAC; 
R: GGACGCAGGCTCTACTTTGATC
SREBP-1C: 
F: CATCGACTACATCCGCTTCTTACA; 
R: GTCTTTCAGTGATTTGCTTTTGTGA
GATA-2: 
F: AATCGGCCGCTCATCAAG; 
R: TCGTCTGACAATTTGCACAACA
Pref-1: 
F: CTGCACTGACCCCATTTGTCT; 
R: TTCCCCCGGTTTGTCACA
LPL: 
F: ACAGTCTTGGAGCCCATGCT; 
R: AGCC 
AGTAATTCTATTGACCTTCTTGT
ACC: 
F: TCCCGGAGCTACTCTTAAAAAATG; 
R: CCCCAACGCCCACATG
FAS: 
F: CTCTGGAAGTGCATGCTGTAAGA; 
R: GGTAGATGTCATTTGCGAAAGGT
SCD-1: 
F: CAACACCATGGCGTTCCA; 
R: GCGTGTGTCTCAGAGAACTTGTG
GLUT4: 
F: ACTCATTCTCGGACGGTTCCT; 
R: CTCCCACATACATAGGCACCAAPerinatal bisphenol A and early adipogenesis
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PPAR-α: 
F: TGGAGTCCACGCATGTGAAG; 
R: CGCCAGCTTTAGCCGAATAG
PGC-1α: 
F: CTGCCATTGTTAAGACCGAGAA; 
R: AGGGACGTCTTTGTGGCTTTT
36B4: 
F: TTCCCACTGGCTGAAAAGGT; 
R: CGCAGCCGCAAATGC
Plasma measurements. We measured 
plasma glucose using the glucose oxidase 
method (Roche Diagnostics GmbH, Rotkreuz, 
Switzerland). Plasma non  esterified fatty acid 
and tri  glyceride levels were determined using 
kits from Wako Chemicals GmbH (Neuss, 
Germany) and Biomérieux (Marcy l’Etoile, 
France), respectively. Plasma cholesterol   
levels were measured as described by James 
and Pometta (1990).
Glucose tolerance test. For the glucose 
tolerance tests, 14-week-old male rats, peri-
natally exposed to BPA, and controls, both 
fed with a high-fat diet since weaning, were 
fasted from the previous day and injected 
intra  peritoneally with 1.5 mg glucose per 
gram of body weight. Blood samples were col-
lected by tail puncture before and at selected 
time points (0, 15, 30, 60, and 120 min) after 
glucose administration in order to measure 
glycemia using a glucose meter (Glucotrend 
Premium, Roche Diagnostics). 
Statistics. Results are expressed as 
mean ± SEM. We performed the unpaired 
Student’s t-test and repeated-measures one-
way analysis of variance (ANOVA) using 
SYSTAT 10.01 (SPSS Inc., Chicago, IL, 
USA). We considered a p-value of < 0.05 sta-
tistically significant. The statistical analyses 
were performed using litter as the fundamen-
tal unit of comparison when appropriate and 
animals originated from at least three differ-
ent litters in each group (eight litters for each 
group for data at birth). To specifically assess 
the significance of the difference in birth 
weight and weaning weight between the con-
trol and BPA groups, we also used a regres-
sion model, taking the correlation between 
the pups from the same litter into account 
[generalized estimating equation (GEE) with 
an exchangeable structure for the working 
correlation matrix]. The factors introduced in 
the model were group, sex, litter size, and the 
inter  action between the sex and group.
Results
Maternal physiology during gestation. To 
evaluate whether BPA exposure during gesta-
tion affected maternal physiology, we meas-
ured weight gain and food and water intake 
of exposed dams during pregnancy. The 
weight gain throughout the pregnancy was 
not significantly different in the BPA-exposed 
dams (135 ± 7 g; mean ± SEM) compared 
with control dams (140 ± 6 g; p = 0.56). Total 
food intake was similar in BPA-exposed dams 
(431 ± 15 g) and control dams (428 ± 16 g; 
p = 0.87) between the start of BPA exposure 
(GD6) and parturition. The daily volume of 
water consumed was unaltered by absence or 
presence of BPA in the water, whatever the 
stage of gestation considered. In fact, at GD7, 
control dams drank 24 ± 1 mL and BPA dams 
drank 25 ± 1 mL (p = 0.76). At GD14, both 
control and BPA dams drank 26 ± 1 mL 
(p = 0.83), and at GD21, control dams drank 
29 ± 2 mL and BPA dams drank 30 ± 2 mL 
(p = 0.88). Based on these measurements, we 
estimated the mean levels of BPA consumed 
daily by pregnant females from the drinking 
water to be approximately 30 µg BPA/dam at 
the end of gestation. Assuming that each ges-
tating dam weighed approximately 428 ± 11 g 
before parturition, we estimated the total BPA 
exposure to be approximately 70 µg/kg/day at 
the end of gestation. Bottle leakage, evapora-
tion, or spillage could result in actual BPA 
exposure being lower than our calculated lev-
els, which represent a maximal estimation.
Body weight of offspring at birth, sex ratio, 
and litter size. On day 1, body weight of male 
pups born to BPA-exposed dams was signifi-
cantly higher (7.33 ± 0.12 g, n = 45 from 
eight litters) compared with those of male 
pups born to control dams (6.91 ± 0.15 g, 
n = 55 from eight litters; p < 0.05). The body 
weight of female pups born to BPA-exposed 
dams was higher on day 1 (7.03 ± 0.11 g, 
n = 50 from eight litters) than that of pups 
born to control dams (6.47 ± 0.12 g, n = 47 
from eight litters; p < 0.001) (Figure 1A,B). 
Despite the fact that the number of pups per 
litter was not statistically different between 
the groups (BPA, 12.7 ± 1.0, n = 8 litters; 
control, 14.1 ± 0.9, n = 8 litters; p = 0.16), 
the elevation of body weight in pups prena-
tally exposed to BPA could have been an indi-
rect effect of BPA via a slight reduction of 
litter size. However, some arguments refute 
this hypothesis. First, when we compared only 
size-matched litters, for analysis (n = 13.5 and 
14 animals per litter in the control and BPA 
groups, respectively), body weight of day-1 
male and female pups born to BPA-exposed 
dams remained higher than that of controls 
(BPA, 7.01 ± 0.08 g, n = 54 animals from four 
litters; control, 6.44 ± 0.08 g, n = 56 animals 
from four litters; p < 0.001). Moreover, when 
we used a regression model, adjusted on the lit-
ter size, to analyze these data (GEE), the day 1 
body weight of BPA-exposed animals remained 
higher, both for male (p < 0.001) and female 
(p < 0.001). Taken together, these observations 
argue in favor of a direct effect of BPA on body 
weight of newborn rats, independent of litter 
size. Finally, we observed that the sex ratio of 
newborn pups was not altered by prenatal BPA 
exposure: The proportion of males per litter 
was similar in control (53 ± 4%) and in BPA-
exposed animals (50 ± 4%; p = 0.31).
Body weight and fat pad weights at wean-
ing. Because offspring were exposed to BPA 
through lactation, we repeated the body weight 
measure  ments of these animals at weaning. On 
PND21, the body weight of BPA-exposed male 
rats (53.36 ± 1.02 g, n = 32) was not different 
from that of controls (52.54 ± 1.11 g, n = 40; 
p = 0.59) (Figure 1C). In contrast, the body 
weight of BPA-exposed female rats remained 
higher (53.73 ± 0.65 g, n = 32) than that of 
controls (47.79 ± 1.44 g, n = 26; p < 0.001) 
(Figure 1D). When the GEE regression model 
was used to analyze these data, the inter-
action between sex and group was significant 
(p = 0.02), and for females, the BPA-induced 
elevation of body weight was statistically signifi-
cant after adjustment for litter size (p = 0.001).
To study the potential impact of BPA 
exposure on body composition, we sacrificed a 
fraction of these animals at weaning (PND21) 
and weighed two different fat pads: inter-
scapular BAT and peri  gonadal white adipose 
tissue (WAT), also called eWAT in males and 
pWAT in females. Interestingly, we found an 
increased trend of eWAT mass in male pups 
exposed to BPA (56 ± 6 mg) compared with 
controls (39 ± 6 mg; p = 0.06), whereas this 
reached significance in BPA-exposed female 
pWAT (95 ± 9 mg) compared with controls 
(33 ± 6 mg; p < 0.001) (Figure 2A,B). BAT 
weight was unchanged in males (Figure 2A) 
Figure 1. Effect of perinatal exposure to 1 mg/L 
BPA on body weight of rat pups at PND1 (A, males; 
B, females) and PND21 (C, males; D, females). 
Results are mean ± SEM. In (A), n = 45 BPA-exposed 
males from eight litters; n = 55 control males from 
eight litters. In (B), n = 50 BPA-exposed females 
from eight litters; n = 47 control females from eight 
litters. In (C), n = 32 BPA-exposed males from six 
litters; n = 40 control males from six litters; p = 0.59. 
In (D), n = 32 BPA-exposed females from six litters; 
n = 26 control females from six litters. 
*p < 0.05, and **p < 0.001, compared with controls.
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but was significantly higher in females exposed 
to BPA (178 ± 13 mg) compared with con-
trols (116 ± 11 mg; p = 0.002) (Figure 2B). 
Moreover, in females, BAT weight correlated 
with pWAT weight (r2 = 0.74, p < 0.001) 
(Figure 2C). These observations suggest that 
the increase in body weight in BPA-exposed 
females is, in part, related to an increase in 
adipose depot weight. In contrast, no change 
was observed in weight (relative to body 
weight) of organs such as heart, liver, or kid-
ney (data not shown). Morphologically, we 
observed no difference in male ano  genital dis-
tance (AGD) (14.8 ± 0.5 mm for controls vs. 
16.1 ± 0.7 mm for BPA animals; p = 0.18), 
but we saw a slight increase in female AGD 
(8.45 ± 0.4 mm for controls vs. 10 ± 0.3 mm 
for BPA animals; p < 0.01) (data not shown). 
Overall, these results suggest that females tend 
to be more sensitive than males to the BPA-
induced fat gain at the dose tested.
Expression of genes involved in adipo  genesis 
and lipogenesis in adipose tissue at weaning. To 
better characterize the early increase in white 
adipose tissue deposition observed in perina-
tally BPA-exposed females pups, we performed 
histologic sections of their pWAT. As shown 
in representative photographs of these tissues 
(Figure 2D), adipocytes of rats peri  natally 
exposed to BPA appeared to be hypertrophied 
compared with those of control animals. These 
histologic observations correlated with changes 
in the expression of genes involved in metab-
olism. mRNA levels of the pro  adipogenic 
transcription factors C/EBP-α, PPAR-γ, and 
SREBP-1C were significantly increased [by 
1.87 ± 0.18-fold (p < 0.001), 2.02 ± 0.17-fold 
(p < 0.001), and 1.97 ± 0.23-fold (p < 0.002), 
respectively] in pWAT of BPA-exposed 
females at weaning (Figure 2E). In contrast, 
mRNA levels of inhibitors of adipogene-
sis, such as GATA-2 and Pref-1 remained 
unchanged (Figure 2E). Gene expression levels 
of lipogenic enzymes such as LPL, FAS, and 
SCD-1 were up-regulated [by 1.28 ± 0.09-fold 
(p < 0.05), 2.55 ± 0.63-fold (p < 0.05), and 
3.10 ± 0.73-fold (p < 0.05), respectively] in 
pWAT of BPA-exposed females (Figure 2F). 
mRNA levels of GLUT4 were also increased 
by 1.59 ± 0.25-fold (p < 0.05; data not shown).
Taken together, these findings strongly 
suggest that perinatal exposure to BPA 
enhances adipogenesis and lipogenesis in vivo 
through an increase of the transcription of 
genes implicated in adipocyte metabolism.
Expression of genes involved in lipo  genesis 
in liver at weaning. Liver is a key organ 
involved in metabolism, as it controls syn-
thesis of many nutrients including lipids and 
carbohydrates. We measured hepatic change 
in expression of several metabolic genes. 
Messenger RNA levels of SREBP-1C were 
significantly increased by 2.07 ± 0.47-fold 
(p < 0.05) in the liver of BPA-exposed females 
at weaning (Figure 3A). In contrast, no change 
was observed in gene expression of the tran-
scription factors PPAR-α and PPAR-gamma-
coactivator 1 alpha (PGC1-α), involved in 
fatty acid oxidation and gluconeogenesis, 
respectively, in this organ. mRNA levels of 
prolipogenic enzymes such as ACC and FAS 
were also up-regulated by 2.17 ± 0.43-fold 
(p < 0.02) and 4.94 ± 1.33-fold (p < 0.01), 
respectively, in the liver of BPA-exposed 
females (Figure 3A). To assess whether these 
early alterations in gene expression were 
related to changes in circulating levels of nutri-
ents, we measured the levels of triglycerides 
(TG), nonesterified fatty acid (NEFA), glu-
cose, and total cholesterol in females pups at 
weaning. We found no statistical difference in 
circulating TG (control, 123.2 ± 12.1 mg/dL; 
BPA 118.8 ± 9.6 mg/dL; p = 0.84; Figure 3B), 
NEFA (control, 0.69 ± 0.04 mmol/L; BPA 
0.80 ± 0.06 mmol/L; p = 0.18; Figure 3C), 
cholesterol (control, 1.45 ± 0.05 g/L; BPA 
1.36 ± 0.02 g/L; p = 0.13; Figure 3D), and 
glucose levels (control, 135.1 ± 3.3 mg/dL; 
BPA 140.6 ± 4.5 mg/dL; p = 0.29; Figure 3E).
Post  weaning body weight. After weaning, 
we weighed perinatally BPA-exposed animals 
weekly from 4 weeks to 14 weeks of age. We 
found no statistical difference in body weight 
between peri  natally BPA-exposed males and 
control males on the standard chow diet 
(Figure 4A). However, peri  natally BPA-
exposed males on a high-fat diet were heavier 
than controls, and a difference of 7 ± 2% of 
body weight at 14 weeks of age (p < 0.05) 
was observed (Figure 4B), suggesting that a 
long-term effect of BPA exists in males only 
when combined with a high caloric intake. In 
contrast, in females we observed differences in 
body weight between peri  natally BPA-exposed 
animals and control animals on both stan-
dard chow and high-fat diets (Figure 4C,D). 
Figure 2. Effect of perinatal exposure to BPA on adipogenesis at weaning (PND21). (A) Weight of eWAT 
and BAT in male rats. (B) Weight of pWAT and interscapular BAT in female rats; data represent 10 animals 
from three independent litters. (C) Correlation between pWAT and BAT weight in female rats (n = 10 animals 
per group; r2 = 0.74; p < 0.001). (D) Representative histologic sections of pWAT from control (top) and BPA-
exposed females (bottom). (E, F) Relative mRNA levels [in arbitrary units (AU)] in pWAT of female rats at 
weaning (n = 9–10 animals in each group from three litters). Results shown in A, B, E, and F are mean ± SEM.
*p < 0.05, **p < 0.001, and #p < 0.002, compared with controls.
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Overall, these results suggest that perinatal 
exposure to BPA increases the susceptibility 
to weight gain in a sex-specific manner, even 
after weaning.
Post  weaning food intake and glucose tol-
erance at adulthood. To evaluate whether 
differences in body weight observed after peri-
natal BPA exposure are related to altered appe-
tite regulation, we measured food intake of 
perinatally BPA-exposed and control rats on 
the standard chow or the high-fat diet from 
week 8 to week 14. During the 7 consecutive 
weeks of meas  ure  ment, despite the known 
caloric hyperphagia induced by the high-fat 
diet, we detected no impact of perinatal BPA 
exposure on daily food intake or cumula-
tive energy intake in males or females eating 
either diet. Perinatally BPA-exposed males on 
the standard diet ingested 3,331 ± 116 kcal 
(vs. 3,308 ± 54 kcal for controls; p = 0.85), 
whereas perinatally BPA-exposed males on 
the high-fat diet consumed 3,931 ± 52 kcal 
(vs. 3,854 ± 111 kcal for controls; p = 0.57). 
Likewise, perinatally BPA-exposed females 
on the standard diet ingested 2,358 ± 58 kcal 
(vs. 2,251 ± 7 kcal for controls; p = 0.15), 
whereas perinatally BPA-exposed females on 
the high-fat diet consumed 2,655 ± 81 kcal 
(vs. 2,510 ± 31 kcal for controls; p = 0.20). 
Therefore, perinatal exposure to BPA did not 
affect post  weaning food intake during growth, 
either in standard conditions or on a high 
caloric diet.
To determine whether the difference 
in body weight in BPA-exposed males fed 
a high-fat diet had an impact on glucose 
homeo  stasis, we performed glucose toler-
ance tests in both BPA-exposed and control 
males on a high-fat diet. Basal glucose levels 
after 16 hr of fasting were similar in control 
rats (4.63 ± 0.10 mmol/L) and BPA-exposed 
rats (4.65 ± 0.08 mmol/L; p = 0.88). After 
intra  peritoneal administration of glucose, the 
circulating glucose clearance was similar in 
both groups (data not shown), reflecting no 
disturbance in glucose utilization. This was 
confirmed by measuring the area under the 
curve, which was equivalent in both BPA-
exposed (1,312 ± 89 mmol/L × min) and 
control animals (1,319 ± 97 mmol/L × min; 
p = 0.96). These results suggest that perinatal 
exposure to BPA has no long-term effects on 
glucose metabolism in the male rat on a high-
fat diet.
Discussion
Many studies have investigated the long-term 
impact of early BPA exposure during stages 
of tissue organization on the male reproduc-
tive tract (Prins et al. 2006; Watanabe et al. 
2003), the female reproductive tract (Suzuki 
et al. 2002; Vandenberg et al. 2007), and 
behavior (Aloisi et al. 2002; Della Seta et al. 
2005; Dessi-Fulgheri et al. 2002; Farabollini 
et al. 2002; Fujimoto et al. 2006; Porrini 
et al. 2005). However, until recently, little 
data on the metabolic effects of perinatal BPA 
exposure were available. The doses we tested 
(1 mg/L in drinking water, corresponding 
to a maximal 70 µg BPA/kg/day exposure 
at the end of gestation, based on water con-
sumed), as well as the oral route of exposure 
chosen (similar to exposure through plastic 
and resin in contact with food), render this 
model rele  vant for humans. Despite the fact 
that this dose cannot be considered truly envi-
ronmentally relevant, it can be considered low 
(Chapin et al. 2008; Melnick et al. 2002).
Maternal physiology (assessed by body 
weight gain, food intake, and volume of water 
Figure 3. Effect of perinatal exposure to BPA on gene expression in liver and circulating metabolites in females at weaning (PND21). (A) Relative mRNA levels [in 
arbitrary units (AU)] in liver (n = 10 animals per group from three litters). Results are means ± SEM. (B–E) Circulating levels of TG (B), NEFA (C), total cholesterol (D), 
and glucose (E) in plasma (n = 10 animals per group from three litters).
*p < 0.05, ##p < 0.01, and †p < 0.02, compared with controls.
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consumed) of the BPA-exposed gestating dams 
was unchanged, as were the sex ratio of pups 
born and number of pups per litter, as previ-
ously reported (Honma et al. 2002; Rubin 
et al. 2001).
In the present study, we confirmed that the 
body weight at birth of both male and female 
pups prenatally exposed to BPA was signifi-
cantly increased. At weaning, after postnatal 
BPA exposure via milk during lactation, the 
body weight of BPA-exposed females, but not 
males, remained higher than controls. These 
observations are in accordance with some pre-
vious publications demonstrating increased 
postnatal growth in different rodent spe-
cies exposed to maternal BPA doses between 
2.4 and 500 µg/kg/day (Howdeshell et al. 
1999; Nikaido et al. 2004; Rubin et al. 2001; 
Takai et al. 2001). However, our present 
data are in contradiction with others works 
reporting no alteration of body weight in pups 
exposed to a very wide range of maternal BPA 
doses, between 0.001 and 5 mg/kg/day (Tyl 
et al. 2002, 2008). Conversely, in these toxicity 
studies, higher doses of BPA administered to 
gestating dams (50–600 mg/kg/day) reduced 
body weight in growing Sprague-Dawley rat 
and CD-1 mouse pups (Tyl et al. 2002, 2008).
In our study we observed that the increase 
in offspring body weight due to BPA exposure 
through placenta and milk was associated with 
an increase in the early adipose storage at wean-
ing in a sex-dependent manner. After perinatal 
exposure to BPA, eWAT demonstrated a trend 
to increase in males, and pWAT was increased 
by nearly 3-fold in females. Our observations 
in Sprague-Dawley rats are in agreement with 
a recent report in which gonadal fat pads were 
heavier in ICR female mice exposed continu-
ously until 30 days of age to the same dose 
of BPA that we used (Miyawaki et al. 2007). 
In the same study, Miyawaki et al. (2007) 
noted that a 10-fold higher dose was ineffi-
cient in inducing over  storage of fat in females 
but was efficient in increasing fat storage in 
males. This led the authors to conclude that 
BPA caused a non  monotonic and inverted 
U-shaped dose–response increase in adipose 
tissue weight in females. Sex-dependent sus-
ceptibility to xeno  estrogens are highly specific 
for a given window of exposure and the kind 
of xenoestrogens used. For example, direct 
oral exposure to genistein (an isoflavone with 
estrogenic activities found mostly in soy) in 
4-week-old mice increased weights of male 
but not female fat pads (Penza et al. 2006), 
whereas in utero exposure to genistein pro-
tected A(vy/a) mice from obesity in association 
with methylation changes of the epigenome 
(Dolinoy et al. 2006). In the same A(vy/a) 
mouse model, in utero exposure to BPA at 
50 mg/kg has also demonstrated epigenetic 
effects, as it decreased CpG methylation in 
an intra  cisternal A particle retro  transposon 
upstream of the Agouti gene (Dolinoy et al. 
2007).
In the present study, we also illustrate 
for the first time that pWAT enlargement 
at weaning in females exposed peri  natally to 
BPA is associated with adipocyte hypertro-
phy, an expanding tissue process more easily 
reversible than hyperplasia, which corresponds 
to an increase in pre  adipocyte recruitment. 
We show that change in size of adipocytes in 
BPA-exposed females is associated with an 
over  expression of proadipogenic transcrip-
tion factors (C/EBP-α  , PPAR-γ, SREBP-1C). 
These in vivo observations are in accordance 
with previous in vitro observations, as BPA 
by itself can accelerate the differentiation of 
3T3-L1 fibroblasts into adipocytes (Masuno 
et al. 2002). The gene expression of lipo-
genic enzymes (LPL, FAS, SCD-1) was also 
up-regulated in the WAT of BPA-exposed 
females, corroborating the in vitro–increased 
levels of lipoprotein lipase mRNAs of 3T3-L1 
cell culture treated with BPA (Masuno et al. 
2005). Finally, we observed an increase in 
mRNA levels of GLUT4 in WAT of BPA-
exposed females, in agreement with the 
in vitro–  enhanced glucose uptake due to an 
increased amount of GLUT4 protein, which 
was observed in 3T3-F442A adipocytes 
treated with BPA (Sakurai et al. 2004). The 
molecular pathways implicated in these pro-
adipogenic effects of BPA are unknown, but it 
has been suggested that the PI3K/Akt pathway 
could be involved (Masuno et al. 2005), as 
BPA increased the level of phosphorylated Akt 
kinase, and LY294002, a chemical inhibitor 
of PI3K, completely abolished the enhancing 
effect of BPA on triglyceride accumulation and 
expression of prolipogenic mRNAs. Finally, 
we show that perinatal BPA exposure is asso-
ciated with an over  expression of lipogenic 
transcription factor and enzymes (SREBP-1C, 
ACC, FAS) in the liver. Again, these in vivo 
observations are in accordance with previous 
in vitro observations in which BPA increased 
lipogenesis through glycerol accumulation 
in the HuH-7 hepato  cellular cell line (Wada 
et al. 2007). At PND21, we found no dif-
ference in circulating levels of tri  glyceride, 
non  esterified fatty acid, and glucose. We also 
failed to detect changes in cholesterol levels 
in perinatally BPA-exposed pups, contrary to 
those observed in ICR mice (Miyawaki et al. 
2007). However, in that study, measurements 
were done at PND30, after consumption of 
a high-fat diet and direct exposure of pups to 
BPA via drinking bottle.
Taken together, these findings provide 
the first clear direct evidence of early gene 
expression alterations in adipose tissue and 
liver after perinatal BPA exposure—an inter-
esting observation, as prevalence of child-
hood obesity is increasing worldwide (Laron 
2004; Micic 2001; Reilly 2005), and some 
countries, such as Canada, prohibit the use of 
BPA in babies’ bottles.
In our study, animals were only indirectly 
exposed through placenta and milk, and BPA 
exposure was stopped at weaning. To uncover 
a possible programming effect of BPA persist-
ing beyond the end of exposure, we investi-
gated possible metabolic disturbances after 
weaning. First, we observed heavier body 
weight during growth in females perinatally 
exposed to BPA, independent of the diet pro-
vided (standard chow or high-fat diet), in line 
with results previously reported by Rubin and 
al. (2001). More surprisingly, BPA males pre-
sented increased body weight during growth 
only when placed on a high-fat diet, suggest-
ing that BPA predisposition to overweight is 
potent only when food is hyper  caloric.
A possible explanation of enhanced weight 
gain in BPA-exposed animals is an increase in 
food intake. In fact, estrogenic action can affect 
neuronal circuits that control appetite by act-
ing on the hypothalamus (Nunez et al. 1980; 
Wade and Schneider 1992). Moreover, based 
on its detection in the brain, BPA is known to 
cross the brain–blood barrier (Sun et al. 2002). 
In this way, we investigated post  weaning food 
intake in perinatally exposed animals fed stan-
dard chow or a high-fat diet. No changes in 
food intake were observed in male or female 
animals perinatally exposed to BPA com-
pared with their respective controls. As body 
weight and energy storage result from a balance 
between energy intake and energy expendi-
ture, this latter parameter could more probably 
explain the difference in body weight observed 
in response to BPA. It should be noted that in 
addition to its estrogenic activities, BPA binds 
and antagonizes the thyroid hormone recep-
tor and therefore inhibits transcriptional activ-
ity stimulated by triiodo  thyronine (Moriyama 
et al. 2002; Zoeller 2005; Zoeller et al. 2005). 
It is conceivable that perinatal BPA exposure 
disrupts the thyroid hormone axis, which itself 
plays a predominant role in thermo  genesis and 
energy expenditure. It is interesting to note 
the preferential accumulation of BPA in BAT 
(Nunez et al. 2001), a major mediator of thy-
roid hormone on thermo  genesis. Additional 
studies are required to better understand the 
precise role of BPA in energy expenditure and 
thermogenesis. Growth hormone could also 
be involved in increased body weight gain in 
relation to perinatal BPA exposure, as it has 
recently been shown that BPA induced growth 
hormone release in vitro in the GH3 pituitary 
cell line (Okada et al. 2007).
In conclusion, the present study demon-
strates that direct exposure to BPA through 
placenta and milk increases early adipose stor-
age and adipogenesis in a sex-specific manner, 
confirming previous observations in ICR mice 
(Miyawaki et al. 2007) and in vitro in 3T3-L1 
and 3T3-F442A adipocyte cell lines (Masuno Perinatal bisphenol A and early adipogenesis
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et al. 2002, 2005; Sakurai et al. 2004). 
Increased adipose storage caused by peri  natal 
BPA exposure could be a major public health 
concern in relation to the epidemic of child-
hood obesity (Laron 2004; Micic 2001; Reilly 
2005). Moreover, because exposure to BPA is 
ubiquitous and does not cease during human 
life (Brotons et al. 1995), further studies are 
urgently needed to better understand the 
long-term consequences of permanent BPA 
exposure on body weight homeo  stasis.
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